Global Epigenetic Therapeutics Supply, Demand and Key Producers, 2023-2029

October 2023 | 95 pages | ID: GDE3806F35B2EN
GlobalInfoResearch

Abstracts

The global Epigenetic Therapeutics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Epigenetic Therapeutics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Epigenetic Therapeutics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Epigenetic Therapeutics that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Epigenetic Therapeutics total market, 2018-2029, (USD Million)

Global Epigenetic Therapeutics total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Epigenetic Therapeutics total market, key domestic companies and share, (USD Million)

Global Epigenetic Therapeutics revenue by player and market share 2018-2023, (USD Million)

Global Epigenetic Therapeutics total market by Type, CAGR, 2018-2029, (USD Million)

Global Epigenetic Therapeutics total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Epigenetic Therapeutics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Astrazeneca, Bristol-Myers Squibb, Clovis Oncology, Gsk Plc, Incyte, Ipsen, Seagen and Servier Laboratories, Ltd., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Epigenetic Therapeutics market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Epigenetic Therapeutics Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Epigenetic Therapeutics Market, Segmentation by Type

• PRAP (Phosphoribosyl Pyrophosphate Amidotransferase) Inhibitor
• Kinase Inhibitor
• IDH (Isocitrate Dehydrogenase) Inhibitor
• HDAC (Histone Deacetylase) Inhibitor
• DNMT (DNA Methyltransferase) Inhibitor

Global Epigenetic Therapeutics Market, Segmentation by Application

• Hospital
• Clinic
• Others

Companies Profiled:

• Astrazeneca
• Bristol-Myers Squibb
• Clovis Oncology
• Gsk Plc
• Incyte
• Ipsen
• Seagen
• Servier Laboratories, Ltd.

Key Questions Answered

1. How big is the global Epigenetic Therapeutics market?

2. What is the demand of the global Epigenetic Therapeutics market?

3. What is the year over year growth of the global Epigenetic Therapeutics market?

4. What is the total value of the global Epigenetic Therapeutics market?

5. Who are the major players in the global Epigenetic Therapeutics market?

Contents

1 SUPPLY SUMMARY

1.1 Epigenetic Therapeutics Introduction
1.2 World Epigenetic Therapeutics Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Epigenetic Therapeutics Total Market by Region (by Headquarter Location)
  1.3.1 World Epigenetic Therapeutics Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Epigenetic Therapeutics Market Size (2018-2029)
  1.3.3 China Epigenetic Therapeutics Market Size (2018-2029)
  1.3.4 Europe Epigenetic Therapeutics Market Size (2018-2029)
  1.3.5 Japan Epigenetic Therapeutics Market Size (2018-2029)
  1.3.6 South Korea Epigenetic Therapeutics Market Size (2018-2029)
  1.3.7 ASEAN Epigenetic Therapeutics Market Size (2018-2029)
  1.3.8 India Epigenetic Therapeutics Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Epigenetic Therapeutics Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Epigenetic Therapeutics Major Market Trends

2 DEMAND SUMMARY

2.1 World Epigenetic Therapeutics Consumption Value (2018-2029)
2.2 World Epigenetic Therapeutics Consumption Value by Region
  2.2.1 World Epigenetic Therapeutics Consumption Value by Region (2018-2023)
  2.2.2 World Epigenetic Therapeutics Consumption Value Forecast by Region (2024-2029)
2.3 United States Epigenetic Therapeutics Consumption Value (2018-2029)
2.4 China Epigenetic Therapeutics Consumption Value (2018-2029)
2.5 Europe Epigenetic Therapeutics Consumption Value (2018-2029)
2.6 Japan Epigenetic Therapeutics Consumption Value (2018-2029)
2.7 South Korea Epigenetic Therapeutics Consumption Value (2018-2029)
2.8 ASEAN Epigenetic Therapeutics Consumption Value (2018-2029)
2.9 India Epigenetic Therapeutics Consumption Value (2018-2029)

3 WORLD EPIGENETIC THERAPEUTICS COMPANIES COMPETITIVE ANALYSIS

3.1 World Epigenetic Therapeutics Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Epigenetic Therapeutics Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Epigenetic Therapeutics in 2022
  3.2.3 Global Concentration Ratios (CR8) for Epigenetic Therapeutics in 2022
3.3 Epigenetic Therapeutics Company Evaluation Quadrant
3.4 Epigenetic Therapeutics Market: Overall Company Footprint Analysis
  3.4.1 Epigenetic Therapeutics Market: Region Footprint
  3.4.2 Epigenetic Therapeutics Market: Company Product Type Footprint
  3.4.3 Epigenetic Therapeutics Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Epigenetic Therapeutics Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Epigenetic Therapeutics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Epigenetic Therapeutics Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Epigenetic Therapeutics Consumption Value Comparison
  4.2.1 United States VS China: Epigenetic Therapeutics Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Epigenetic Therapeutics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Epigenetic Therapeutics Companies and Market Share, 2018-2023
  4.3.1 United States Based Epigenetic Therapeutics Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Epigenetic Therapeutics Revenue, (2018-2023)
4.4 China Based Companies Epigenetic Therapeutics Revenue and Market Share, 2018-2023
  4.4.1 China Based Epigenetic Therapeutics Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Epigenetic Therapeutics Revenue, (2018-2023)
4.5 Rest of World Based Epigenetic Therapeutics Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Epigenetic Therapeutics Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Epigenetic Therapeutics Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Epigenetic Therapeutics Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 PRAP (Phosphoribosyl Pyrophosphate Amidotransferase) Inhibitor
  5.2.2 Kinase Inhibitor
  5.2.3 IDH (Isocitrate Dehydrogenase) Inhibitor
  5.2.4 HDAC (Histone Deacetylase) Inhibitor
  5.2.5 DNMT (DNA Methyltransferase) Inhibitor
5.3 Market Segment by Type
  5.3.1 World Epigenetic Therapeutics Market Size by Type (2018-2023)
  5.3.2 World Epigenetic Therapeutics Market Size by Type (2024-2029)
  5.3.3 World Epigenetic Therapeutics Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Epigenetic Therapeutics Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Hospital
  6.2.2 Clinic
  6.2.3 Others
6.3 Market Segment by Application
  6.3.1 World Epigenetic Therapeutics Market Size by Application (2018-2023)
  6.3.2 World Epigenetic Therapeutics Market Size by Application (2024-2029)
  6.3.3 World Epigenetic Therapeutics Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Astrazeneca
  7.1.1 Astrazeneca Details
  7.1.2 Astrazeneca Major Business
  7.1.3 Astrazeneca Epigenetic Therapeutics Product and Services
  7.1.4 Astrazeneca Epigenetic Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Astrazeneca Recent Developments/Updates
  7.1.6 Astrazeneca Competitive Strengths & Weaknesses
7.2 Bristol-Myers Squibb
  7.2.1 Bristol-Myers Squibb Details
  7.2.2 Bristol-Myers Squibb Major Business
  7.2.3 Bristol-Myers Squibb Epigenetic Therapeutics Product and Services
  7.2.4 Bristol-Myers Squibb Epigenetic Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 Bristol-Myers Squibb Recent Developments/Updates
  7.2.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
7.3 Clovis Oncology
  7.3.1 Clovis Oncology Details
  7.3.2 Clovis Oncology Major Business
  7.3.3 Clovis Oncology Epigenetic Therapeutics Product and Services
  7.3.4 Clovis Oncology Epigenetic Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Clovis Oncology Recent Developments/Updates
  7.3.6 Clovis Oncology Competitive Strengths & Weaknesses
7.4 Gsk Plc
  7.4.1 Gsk Plc Details
  7.4.2 Gsk Plc Major Business
  7.4.3 Gsk Plc Epigenetic Therapeutics Product and Services
  7.4.4 Gsk Plc Epigenetic Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Gsk Plc Recent Developments/Updates
  7.4.6 Gsk Plc Competitive Strengths & Weaknesses
7.5 Incyte
  7.5.1 Incyte Details
  7.5.2 Incyte Major Business
  7.5.3 Incyte Epigenetic Therapeutics Product and Services
  7.5.4 Incyte Epigenetic Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Incyte Recent Developments/Updates
  7.5.6 Incyte Competitive Strengths & Weaknesses
7.6 Ipsen
  7.6.1 Ipsen Details
  7.6.2 Ipsen Major Business
  7.6.3 Ipsen Epigenetic Therapeutics Product and Services
  7.6.4 Ipsen Epigenetic Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Ipsen Recent Developments/Updates
  7.6.6 Ipsen Competitive Strengths & Weaknesses
7.7 Seagen
  7.7.1 Seagen Details
  7.7.2 Seagen Major Business
  7.7.3 Seagen Epigenetic Therapeutics Product and Services
  7.7.4 Seagen Epigenetic Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 Seagen Recent Developments/Updates
  7.7.6 Seagen Competitive Strengths & Weaknesses
7.8 Servier Laboratories, Ltd.
  7.8.1 Servier Laboratories, Ltd. Details
  7.8.2 Servier Laboratories, Ltd. Major Business
  7.8.3 Servier Laboratories, Ltd. Epigenetic Therapeutics Product and Services
  7.8.4 Servier Laboratories, Ltd. Epigenetic Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 Servier Laboratories, Ltd. Recent Developments/Updates
  7.8.6 Servier Laboratories, Ltd. Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Epigenetic Therapeutics Industry Chain
8.2 Epigenetic Therapeutics Upstream Analysis
8.3 Epigenetic Therapeutics Midstream Analysis
8.4 Epigenetic Therapeutics Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Epigenetic Therapeutics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Epigenetic Therapeutics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Epigenetic Therapeutics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Epigenetic Therapeutics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Epigenetic Therapeutics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Epigenetic Therapeutics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Epigenetic Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Epigenetic Therapeutics Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Epigenetic Therapeutics Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Epigenetic Therapeutics Players in 2022
Table 12. World Epigenetic Therapeutics Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Epigenetic Therapeutics Company Evaluation Quadrant
Table 14. Head Office of Key Epigenetic Therapeutics Player
Table 15. Epigenetic Therapeutics Market: Company Product Type Footprint
Table 16. Epigenetic Therapeutics Market: Company Product Application Footprint
Table 17. Epigenetic Therapeutics Mergers & Acquisitions Activity
Table 18. United States VS China Epigenetic Therapeutics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Epigenetic Therapeutics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Epigenetic Therapeutics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Epigenetic Therapeutics Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Epigenetic Therapeutics Revenue Market Share (2018-2023)
Table 23. China Based Epigenetic Therapeutics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Epigenetic Therapeutics Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Epigenetic Therapeutics Revenue Market Share (2018-2023)
Table 26. Rest of World Based Epigenetic Therapeutics Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Epigenetic Therapeutics Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Epigenetic Therapeutics Revenue Market Share (2018-2023)
Table 29. World Epigenetic Therapeutics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Epigenetic Therapeutics Market Size by Type (2018-2023) & (USD Million)
Table 31. World Epigenetic Therapeutics Market Size by Type (2024-2029) & (USD Million)
Table 32. World Epigenetic Therapeutics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Epigenetic Therapeutics Market Size by Application (2018-2023) & (USD Million)
Table 34. World Epigenetic Therapeutics Market Size by Application (2024-2029) & (USD Million)
Table 35. Astrazeneca Basic Information, Area Served and Competitors
Table 36. Astrazeneca Major Business
Table 37. Astrazeneca Epigenetic Therapeutics Product and Services
Table 38. Astrazeneca Epigenetic Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Astrazeneca Recent Developments/Updates
Table 40. Astrazeneca Competitive Strengths & Weaknesses
Table 41. Bristol-Myers Squibb Basic Information, Area Served and Competitors
Table 42. Bristol-Myers Squibb Major Business
Table 43. Bristol-Myers Squibb Epigenetic Therapeutics Product and Services
Table 44. Bristol-Myers Squibb Epigenetic Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Bristol-Myers Squibb Recent Developments/Updates
Table 46. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 47. Clovis Oncology Basic Information, Area Served and Competitors
Table 48. Clovis Oncology Major Business
Table 49. Clovis Oncology Epigenetic Therapeutics Product and Services
Table 50. Clovis Oncology Epigenetic Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Clovis Oncology Recent Developments/Updates
Table 52. Clovis Oncology Competitive Strengths & Weaknesses
Table 53. Gsk Plc Basic Information, Area Served and Competitors
Table 54. Gsk Plc Major Business
Table 55. Gsk Plc Epigenetic Therapeutics Product and Services
Table 56. Gsk Plc Epigenetic Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Gsk Plc Recent Developments/Updates
Table 58. Gsk Plc Competitive Strengths & Weaknesses
Table 59. Incyte Basic Information, Area Served and Competitors
Table 60. Incyte Major Business
Table 61. Incyte Epigenetic Therapeutics Product and Services
Table 62. Incyte Epigenetic Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Incyte Recent Developments/Updates
Table 64. Incyte Competitive Strengths & Weaknesses
Table 65. Ipsen Basic Information, Area Served and Competitors
Table 66. Ipsen Major Business
Table 67. Ipsen Epigenetic Therapeutics Product and Services
Table 68. Ipsen Epigenetic Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Ipsen Recent Developments/Updates
Table 70. Ipsen Competitive Strengths & Weaknesses
Table 71. Seagen Basic Information, Area Served and Competitors
Table 72. Seagen Major Business
Table 73. Seagen Epigenetic Therapeutics Product and Services
Table 74. Seagen Epigenetic Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Seagen Recent Developments/Updates
Table 76. Servier Laboratories, Ltd. Basic Information, Area Served and Competitors
Table 77. Servier Laboratories, Ltd. Major Business
Table 78. Servier Laboratories, Ltd. Epigenetic Therapeutics Product and Services
Table 79. Servier Laboratories, Ltd. Epigenetic Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 80. Global Key Players of Epigenetic Therapeutics Upstream (Raw Materials)
Table 81. Epigenetic Therapeutics Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Epigenetic Therapeutics Picture
Figure 2. World Epigenetic Therapeutics Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Epigenetic Therapeutics Total Market Size (2018-2029) & (USD Million)
Figure 4. World Epigenetic Therapeutics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Epigenetic Therapeutics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Epigenetic Therapeutics Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Epigenetic Therapeutics Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Epigenetic Therapeutics Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Epigenetic Therapeutics Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Epigenetic Therapeutics Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Epigenetic Therapeutics Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Epigenetic Therapeutics Revenue (2018-2029) & (USD Million)
Figure 13. Epigenetic Therapeutics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Epigenetic Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 16. World Epigenetic Therapeutics Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Epigenetic Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 18. China Epigenetic Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Epigenetic Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Epigenetic Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Epigenetic Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Epigenetic Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 23. India Epigenetic Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Epigenetic Therapeutics by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Epigenetic Therapeutics Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Epigenetic Therapeutics Markets in 2022
Figure 27. United States VS China: Epigenetic Therapeutics Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Epigenetic Therapeutics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Epigenetic Therapeutics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Epigenetic Therapeutics Market Size Market Share by Type in 2022
Figure 31. PRAP (Phosphoribosyl Pyrophosphate Amidotransferase) Inhibitor
Figure 32. Kinase Inhibitor
Figure 33. IDH (Isocitrate Dehydrogenase) Inhibitor
Figure 34. HDAC (Histone Deacetylase) Inhibitor
Figure 35. DNMT (DNA Methyltransferase) Inhibitor
Figure 36. World Epigenetic Therapeutics Market Size Market Share by Type (2018-2029)
Figure 37. World Epigenetic Therapeutics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Epigenetic Therapeutics Market Size Market Share by Application in 2022
Figure 39. Hospital
Figure 40. Clinic
Figure 41. Others
Figure 42. Epigenetic Therapeutics Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source